(Q54525200)

30 May 2018

title

Neuroendocrine evidence for increased responsiveness of dopamine receptors in humans following electroconvulsive therapy. (English)

1 reference

30 May 2018

1

J Balldin

1 reference

30 May 2018

author name string

A K Granérus

2

1 reference

30 May 2018

G Lindstedt

3

1 reference

30 May 2018

K Modigh

4

1 reference

30 May 2018

J Wålinder

5

1 reference

30 May 2018

publication date

1 January 1982

1 reference

30 May 2018

published in

Psychopharmacology

1 reference

30 May 2018

volume

76

1 reference

30 May 2018

issue

4

1 reference

30 May 2018

page(s)

371-376

1 reference

30 May 2018

https://scigraph.springernature.com/pub.10.1007/bf00449127

exact match

0 references

cites work

A neuroendocrine study of supersensitivity in tardive dyskinesia.

1 reference

12 December 2020

Effect of apomorphine on growth hormone, prolactin, luteinizing hormone and follicle-stimulating hormone levels in human serum

1 reference

12 December 2020

Production and processing of prolactin

1 reference

12 December 2020

Effects of electroconvulsive treatment on growth hormone secretion induced by monoamine receptor agonists in reserpine-pretreated rats

1 reference

12 December 2020

Effect of Apomorphine on Growth Hormone Release in Humans1

1 reference

12 December 2020

Effects of apomorphine and clonidine on rat plasma growth hormone after pretreatment with reserpine and electroconvulsive shocks

1 reference

12 December 2020

Experimental studies of the therapeutic action of electroconvulsive therapy in endogenous depression. The role of the electrical stimulation and of the seizure studied by variation of stimulus intensity and modification by lidocaine of seizure disch

1 reference

12 December 2020

Dopaminergic stimulation of prolactin release

1 reference

12 December 2020

Neuroendocrine tests of monoamine function in man: a review of basic theory and its application to the study of depressive illness

1 reference

12 December 2020

Effect of electroconvulsive shock on monoaminergic receptor binding sites in rat brain

1 reference

12 December 2020

Electroconvulsive therapy in Parkinson's syndrome with "on-off" phenomenon

1 reference

12 December 2020

Repeated electroconvulsive shock increases the behavioural responses of rats to injection of both dopamine and dibutyryl cyclic amp into the nucleus accumbens

1 reference

12 December 2020

Enzymatic iodination of polypeptides with 125I to high specific activity.

1 reference

12 December 2020

Uptake inhibition of biogenic amines by newer antidepressant drugs: Relevance to the dopamine hypothesis of depression

1 reference

12 December 2020

Central Monoamine Deficiency in Depressions: Causative or Secondary Phenomenon?*

1 reference

12 December 2020

Further observations on the effect of repeated electroconvulsive shock on the behavioural resposes of rats produced by increases in the functional activity of brain 5-hydroxytryptamine and dopamine

1 reference

12 December 2020

Effect of apomorphine on human-growth-hormone secretion.

1 reference

12 December 2020

Electroconvulsive shock and postsynaptic catecholamine effects: Increased psychomotor stimulant action of apomorphine and clonidine in reserpine pretreated mice by repeated ECS

1 reference

12 December 2020

Dopamine receptor sensitivity in the hypothalamus of chronic schizophrenics after haloperidol therapy: Growth hormone and prolactin response to stimuli

1 reference

12 December 2020

International reliability and communicability of a rating scale for depression

1 reference

12 December 2020

Predictors for improvement after electroconvulsive therapy in parkinsonian patients with on-off symptoms

1 reference

12 December 2020

Central monoamine metabolism in depressions. II. Catecholamines and related compounds

1 reference

12 December 2020

Changes in Plasma Growth Hormone Levels in Normal and Acromegalic Subjects Following Administration of 2-Bromo-α-Ergocryptine

1 reference

12 December 2020

Inhibitory Effect of Dopaminergic Stimulation on GH Release in Acromegaly

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00449127

1 reference

30 May 2018

1 reference

30 May 2018